These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35658334)

  • 1. Situating Food Industry Influence: Governance Norms and Economic Order Comment on "'Part of the Solution': Food Corporation Strategies for Regulatory Capture and Legitimacy".
    Lencucha R
    Int J Health Policy Manag; 2022 Dec; 11(11):2736-2739. PubMed ID: 35658334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A World Beyond Transnational Corporations: Meeting Human Rather Than Corporate Need Comment on "'Part of the Solution': Food Corporation Strategies for Regulatory Capture and Legitimacy".
    Baum F; Anaf J
    Int J Health Policy Manag; 2022 Dec; 11(11):2748-2751. PubMed ID: 36300255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trust, but Verify Comment on "'Part of the Solution': Food Corporation Strategies for Regulatory Capture and Legitimacy".
    Allen LN
    Int J Health Policy Manag; 2022 Dec; 11(11):2727-2731. PubMed ID: 35247935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying a Commercial Determinants of Health Lens to Understand, Expose and Counter Industry Co-option, Appeasement and Partnership Comment on "'Part of the Solution': Food Corporation Strategies for Regulatory Capture and Legitimacy".
    Crosbie E; Carriedo A
    Int J Health Policy Manag; 2022 Dec; 11(11):2744-2747. PubMed ID: 35942972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responding to Food Industry Initiatives to Be "Part of the Solution" Comment on "'Part of the Solution': Food Corporation Strategies for Regulatory Capture and Legitimacy".
    Freudenberg N
    Int J Health Policy Manag; 2022 Dec; 11(11):2740-2743. PubMed ID: 35942965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Foundations of Corporate Strategies Comment on "'Part of the Solution': Food Corporation Strategies for Regulatory Capture and Legitimacy".
    Wiist WH
    Int J Health Policy Manag; 2022 Dec; 11(11):2732-2735. PubMed ID: 35397485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Part of the Solution": Food Corporation Strategies for Regulatory Capture and Legitimacy.
    Lacy-Nichols J; Williams O
    Int J Health Policy Manag; 2021 Dec; 10(12):845-856. PubMed ID: 34634883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corporate interest groups and their implications for global food governance: mapping and analysing the global corporate influence network of the transnational ultra-processed food industry.
    Slater S; Lawrence M; Wood B; Serodio P; Baker P
    Global Health; 2024 Feb; 20(1):16. PubMed ID: 38388413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the corporate political activity of major food industry actors in Fiji.
    Mialon M; Swinburn B; Wate J; Tukana I; Sacks G
    Global Health; 2016 May; 12(1):18. PubMed ID: 27160250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food industry political practices in Chile: "the economy has always been the main concern".
    Mialon M; Corvalan C; Cediel G; Scagliusi FB; Reyes M
    Global Health; 2020 Oct; 16(1):107. PubMed ID: 33109216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Political Economy of Healthy and Sustainable Food Systems: An Introduction to a Special Issue.
    Baker P; Lacy-Nichols J; Williams O; Labonté R
    Int J Health Policy Manag; 2021 Nov; 10(12):734-744. PubMed ID: 34836454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of economic policy uncertainty on corporate social responsibility: A new evidence from food industry in China.
    Su F; Song N; Shang H; Fahad S
    PLoS One; 2022; 17(6):e0269165. PubMed ID: 35687589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How commercial actors used different types of power to influence policy on restricting food marketing: a qualitative study with policy actors in Thailand.
    Phulkerd S; Collin J; Ngqangashe Y; Thow AM; Schram A; Huckel Schneider C; Friel S
    BMJ Open; 2022 Oct; 12(10):e063539. PubMed ID: 36229148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-regulation and alcohol industry political strategy: A case study of the Public Health England-Drinkaware Drink Free Days Campaign.
    Hawkins B; Durrance-Bagale A; Walls H
    Soc Sci Med; 2021 Sep; 285():114175. PubMed ID: 34388623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of corporate market power on health: exploring the structure-conduct-performance model from a public health perspective.
    Wood B; Williams O; Baker P; Nagarajan V; Sacks G
    Global Health; 2021 Apr; 17(1):41. PubMed ID: 33823900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taking on the Corporate Determinants of Ill-health and Health Inequity: A Scoping Review of Actions to Address Excessive Corporate Power to Protect and Promote the Public's Health.
    Wood B; Lacy-Nichols J; Sacks G
    Int J Health Policy Manag; 2023; 12():7304. PubMed ID: 38618808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The World Health Organization, Corporate Power, and the Prevention and Management of Conflicts of Interest in Nutrition Policy Comment on "Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool".
    Fooks GJ; Godziewski C
    Int J Health Policy Manag; 2022 Feb; 11(2):228-232. PubMed ID: 32861232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redressing the Corporate Cultivation of Consumption: Releasing the Weapons of the Structurally Weak.
    Friel S
    Int J Health Policy Manag; 2021 Dec; 10(12):784-792. PubMed ID: 33131225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. It Is Not Enough to Assess Conflicts of Interest When We Bring the Commercial Sector to the Policy Table Comment on "Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool".
    Chilet-Rosell E; Hernández-Aguado I
    Int J Health Policy Manag; 2022 Mar; 11(3):394-397. PubMed ID: 34814673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.